The Federal Trade Commission (FTC) has asked a US federal judge to hold “pharma bro” Martin Shkreli in contempt for forming another drug company that it said violates a...
15.07.2016
- A US federal judge has set Jun. 26, 2017 as the trial date for Martin Shkreli, the 33-year-old founder of Retrophin and Turing Pharmaceuticals and former CEO of KalaBios as well as...
21.03.2016
- The former general counsel of Turing Pharmaceuticals said on Thursday that he and other executives had repeatedly objected to a plan by Martin Shkreli, then chief executive, to...
09.02.2016
- Martin Shkreli, the 32-year-old former CEO of Turing Pharmaceuticals who made negative headlines last year after jacking up the price of the toxmoplasmosis drug Daraprim...
05.01.2016
- Goldberg Law PC has announced a class action suit against KaloBios Pharmaceuticals, charging that the company, until recently headed by industry “bad boy” Martin Shkreli, may have...
22.12.2015
- Martin Shkreli, CEO of Turing Pharma, which made headlines by raising the price of the 62-year-old drug, Daraprim (pyrimethamine) from $13.50 to $700 a tablet shortly after...
30.09.2015
- Shares of US-listed Canadian drugmaker Valeant came under additional severe pressure early this week when Democratic party members on the House of Representative committee on...
25.09.2015
- Turing Pharmaceutical, the company that sparked an angry backlash for raising the US price of Daraprim (pyrimethamine), a drug for treating the deadly parasitic infection...
